29 Jul 2021 16:30
Ap24
Â
AMENDMENT
FORMÂ 38.5(a)
Â
IRISHÂ TAKEOVERÂ PANEL
Â
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
Â
DEALINGSÂ BYÂ CONNECTEDÂ EXEMPTÂ PRINCIPALÂ TRADERSÂ WITHÂ RECOGNISEDÂ INTERMEDIARYÂ STATUSÂ ANDÂ DEALINGÂ INÂ AÂ CLIENT-SERVINGÂ CAPACITY
Â
1. KEYÂ INFORMATION
Â
Name of exempt principal trader | J.P. Morgan Securities Plc |
Company dealt in | UDG Healthcare Plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | €0.05 ordinary shares |
Date of dealing | 9 July 2021 |
Â
2. DEALINGS (Note 2)
Â
(a) Purchases and sales
Â
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
101,185 | 10.7598 GBP | 10.7200 GBP |
Â
Â
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
259,109 | 10.9900 GBP | 10.6900 GBP |
Â
Â
(b) Derivatives transactions (other than options transactions)
Â
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
Equity Swap | Decrease Long   Decrease Short        Increase Long       Increase Short     Opening a long position      Opening a short position  | 495  2,392   8  15,624  9,325  500  110,540  2,098  5,000   1,300  1,070  4,170  1,437  369  1   9,520  8,062  27,418  950   13,190  10,595  6,470  3,377  13,312   1,146  2,056  54  15,105  14,804  1,227  12,552 | 10.7354 GBP 10.7402 GBP
10.7200 GBP 10.7268 GBP 10.7305 GBP 10.7335 GBP 10.7374 GBP 10.7385 GBP 10.7387 GBP
10.7346 GBP 10.7348 GBP 10.7357 GBP 10.7397 GBP 10.7399 GBP 10.9892 GBP
10.7267 GBP 10.7407 GBP 10.7461 GBP 10.7504 GBP
10.7191 GBP 10.7194 GBP 10.7300 GBP 10.7305 GBP 10.7400 GBP
10.7251 GBP 10.7350 GBP 10.7353 GBP 10.7401 GBP 10.7405 GBP 10.7406 GBP 10.7509 GBP |
Â
Ap25
Â
(c) Options transactions in respect of existing relevant securities
Â
Â
(i) Writing, selling, purchasing or varying
Â
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
 |  |  |  |  |  |  |
Â
Â
(ii) Exercising
Â
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
 |  |  |
Â
Â
3. Â OTHERÂ INFORMATION
Â
Agreements, arrangements or understandings relating to options or derivatives
Â
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Â
Â
Â
Â
Â
Â
Date of disclosure | 29 July 2021 |
Contact name | Alwyn Basch |
Telephone number | 020 7742 7407 |
Name of offeree/offeror with which connected | UDG Healthcare Plc |
Nature of connection (Note 6) | Financial adviser to CD&R Fund XI |
Â
Follow the stocks